Zhejiang Huahai Pharmaceutical is recalling the valsartan drug sold in the United States after the European Medicines Agency found that it was tainted with an impurity linked to cancer. Photo: Weibo
Zhejiang Huahai Pharmaceutical is recalling the valsartan drug sold in the United States after the European Medicines Agency found that it was tainted with an impurity linked to cancer. Photo: Weibo
Health in China
China /  Politics

Beijing orders made-in-China valsartan heart drug pulled from hospitals over cancer risks

Zhejiang Huahai Pharmaceutical version should not be used for treatment or diagnosis, health regulator says

Reuters
Reuters

Updated: 11:21pm, 30 Jul, 2018

Why you can trust SCMP
Zhejiang Huahai Pharmaceutical is recalling the valsartan drug sold in the United States after the European Medicines Agency found that it was tainted with an impurity linked to cancer. Photo: Weibo
Zhejiang Huahai Pharmaceutical is recalling the valsartan drug sold in the United States after the European Medicines Agency found that it was tainted with an impurity linked to cancer. Photo: Weibo
READ FULL ARTICLE